2. Protein Tyrosine Kinase/RTK
  3. VEGFR
  4. EG01449

EG01449 is a quinoline-based antagonist of Neuropilin-1 (NRP1) with an Kd of 0.6 µM. EG01449 competitively inhibits the binding of VEGFA to NRP1 with an IC50 of 362 nM. EG01449 prevents VEGFA-induced pain by inhibiting NRP1-dependent signaling and reducing sodium currents in sensory neurons. EG01449 can be used for the research of nociceptive pain.

For research use only. We do not sell to patients.

EG01449

EG01449 Chemical Structure

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Other Forms of EG01449:

EG01449 Related Antibodies

Top Publications Citing Use of Products

View All VEGFR Isoform Specific Products:

View All Isoforms
VEGFR1/Flt-1 VEGFR2/KDR/Flk-1 VEGFR3/Flt-4

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

EG01449 is a quinoline-based antagonist of Neuropilin-1 (NRP1) with an Kd of 0.6 µM. EG01449 competitively inhibits the binding of VEGFA to NRP1 with an IC50 of 362 nM. EG01449 prevents VEGFA-induced pain by inhibiting NRP1-dependent signaling and reducing sodium currents in sensory neurons. EG01449 can be used for the research of nociceptive pain[1].

In Vitro

EG01449 (30 μM; Preincubation for 15 min) reduces VEGFA-induced phosphorylation of p38 in retinal endothelium and hCMEC/D3[1].
EG01449 (30 μM; Excised Rat Lumbar DRG Neurons) reduces VEGFA165-induced increase in sodium currents. EG01449 alone has any obvious effect on Na+ currents[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

EG01449 Related Antibodies

Western Blot Analysis[1]

Cell Line: Vascular endothelial cells of the ex vivo mouse retina and Human brain endothelial line hCMEC/D3
Concentration: 30 μM
Incubation Time: Preincubated for 15 min and then treated with VEGFA for 5 min.
Result: VEGFA-induced phosphorylation of p38 phosphorylation was inhibited.
Parmacokinetics
Species Dose Route Note AUC Plasma Concentration Clearance (CL) T1/2 Tmax Cmax Vd
Mice 2 mg/kg i.v. 文献审核 1367 ng·h/mL 5181 ng/mL 24.33 mL/min/kg 1.3 h 0.08 h 5181 ng/mL 394 mL/kg
In Vivo

EG01449 (10, 30 μM; Intraplantar injection; once) significantly reduces VEGFA-induced aversion to mechanical stimuli and VEGFA-induced mechanical and cold allodynia in Sprague-Dawley rat[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Male and female rats (6 weeks old) were given an intraplantar injection in the hind-paw containing VEGFA165 (10 nM)[1]
Dosage: 10 μM, 30 μM
Administration: Intraplantar injection; once
Result: Significantly reduced VEGFA-induced mechanical allodynia in both male and female rats at 30 μM. At 10 μM, significant reduction in mechanical allodynia in males but not in females. Additionally, significantly reduced VEGFA-induced cold allodynia in females at 30 μM, but not at 10 μM. No significant effects were observed in females at 10 μM.
Animal Model: Male and female rats (6 weeks old) were given an intraplantar injection in the hind-paw containing VEGFA165 (10 nM)[1]
Dosage: 10 μM, 30 μM
Administration: Intraplantar injection; once
Result: Significantly reduced VEGFA-induced aversion to mechanical stimuli in both male and female rats at 30 μM. At 10 μM, significant reduction in aversion in males but not in females. No significant effects were observed in females at 10 μM.
Molecular Weight

732.85

Formula

C29H36N10O7S3
SMILES

O=C([C@H](CCCNC(N)=N)NC(C1=C(C=CS1)NS(=O)(C2=C3N=CC=CC3=CC(NCC4=CSC(N5CCNCC5)=N4)=C2)=O)=O)O.O=CO
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

EG01449 Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

EG01449EG 01449EG-01449VEGFRVascular endothelial growth factor receptorneuropilin antinociceptive chronic pain VEGF NRP1Inhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
EG01449
Cat. No.:
HY-179350A
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

SAFETY DATA SHEET (SDS)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.